undamentalytics Newsletter

Wynnefield Capital, Inc. Profit Sharing Plan: insider trades

10% owner at 6 companies we cover. 11 open-market purchases and 4 sales not made under a pre-set plan, reported from September 20, 2012 to October 7, 2024.

Would copying Wynnefield Capital, Inc. Profit Sharing Plan’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 8 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on May 20, 2016 into $8,337 by November 2, 2026, −1.7% a year. The copy held shares only 52% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $16,736, +5.1% a year (the S&P 500 held throughout made $43,551, +15.2% a year). Beta against the index was 0.65. Twelve months after each report, the average purchase was +5.4% against the S&P 500 (median +7.3%), and 63% beat it. Measured from the trade date, the insider’s own timing, the average was +3.3%. After their sales, the shares moved −0.5% against the index over 12 months on average (a negative figure means selling was the right call); 67% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k 201620182020202220242026 $43.6k$16.7k$8.3k
Copying Wynnefield Capital, Inc. Profit Sharing PlanS&P 500, same days investedS&P 500, held throughout $10,000 copying Wynnefield Capital, Inc. Profit Sharing Plan’s open-market purchases from May 20, 2016, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−1.7%
S&P 500, same days invested
+5.1% (held throughout +15.2%)
Time in shares
52%
Sharpe ratio (S&P 500)
0.08 (0.75)
Biggest drop (S&P 500)
−75% (−34%)
Market sensitivity (beta)
0.65
Purchases copied
8

Trade by trade

Wynnefield Capital, Inc. Profit Sharing Plan: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 8 +6.1% −8.6% 38% 5 0.50 0.65 No reliable evidence
Purchases, 6 months after the report 8 +16.9% +11.8% 63% 5 0.56 0.60 No reliable evidence
Purchases, 12 months after the report 8 +5.4% +7.3% 63% 5 −0.60 0.58 No reliable evidence
Purchases, 12 months after the trade 8 +3.3% +5.9% 50% 5 −0.66 0.54 No reliable evidence
Sales, 3 months after the report 3 −8.5% −15.8% 67% 2 — — Not enough years
Sales, 12 months after the report 3 −0.5% −12.2% 67% 2 — — Not enough years
Sales, 12 months after the trade 3 +2.0% −1.1% 67% 2 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Natures Sunshine Products Inc NATR —60May 19, 2016September 12, 2022
Quest Resource Holding Corp QRHC —30April 8, 2022March 15, 2024
Lifecore Biomedical, Inc. DE LFCR —11September 20, 2012October 7, 2024
Crown Crafts Inc CRWS —02December 5, 2012January 23, 2013
Telos Corp TLS —10July 14, 2015July 14, 2015
DLH Holdings Corp. DLHC —01March 12, 2019March 12, 2019

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
October 7, 2024October 3, 2024 LFCR Purchase $1,200,000 not yetnot yetnot yet
March 15, 2024March 13, 2024 QRHC Purchase $212,197 +21.8%−69.2%−71.6%
September 12, 2022September 8, 2022 NATR Purchase $41,087 −9.9%+62.5%+60.7%
September 6, 2022September 1, 2022 NATR Purchase $81,832 −7.3%+62.6%+52.4%
June 6, 2022June 2, 2022 QRHC Purchase $250,466 not yetnot yetnot yet
April 8, 2022April 6, 2022 QRHC Purchase $126,405 −16.1%+4.4%−1.0%
May 21, 2019May 16, 2019 NATR Purchase $48,495 −12.0%−14.8%−10.3%
March 12, 2019March 8, 2019 DLHC Sale $1,324,078 −17.5%−17.1%−19.0%
November 21, 2017November 17, 2017 NATR Purchase $102,246 −13.4%−32.2%−31.1%
May 25, 2016May 23, 2016 NATR Purchase $18,216 +49.9%+20.0%+14.1%
May 19, 2016May 17, 2016 NATR Purchase $101,937 +36.0%+10.3%+12.9%
July 14, 2015July 10, 2015 TLS Purchase $909,500 not yetnot yetnot yet
January 23, 2013January 18, 2013 CRWS Sale $65,300 not yetnot yetnot yet
December 5, 2012December 3, 2012 CRWS Sale $251,340 +7.8%+27.9%+26.2%
September 20, 2012September 18, 2012 LFCR Sale $2,775,675 −15.8%−12.2%−1.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Wynnefield Capital, Inc. Profit Sharing Plan traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.